AMGEN ANNOUNCES WEBCAST OF 2022 CREDIT SUISSE GLOBAL HEALTHCARE CONFERENCE
Amgen will present at the Credit Suisse 31st Annual Global Healthcare Conference on November 9, 2022, at 3:50 p.m. ET. Key executives, including David M. Reese, M.D., and Peter H. Griffith, will speak at the event. The presentation will be available via webcast for media, investors, and the public, with an archive accessible for 90 days afterward. Amgen, a leading biotechnology company, focuses on developing innovative therapies for serious illnesses and is included in the Dow Jones Industrial Average. For further details, visit Amgen's investor relations page.
- None.
- None.
THOUSAND OAKS, Calif., Nov. 4, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Credit Suisse 31st Annual Global Healthcare Conference at 3:50 p.m. ET on Wednesday, November 9, 2022. David M. Reese, M.D., executive vice president of Research and Development and Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2022, Amgen was named one of the "World's Best Employers" by Forbes and one of "America's 100 Most Sustainable Companies" by Barron's.
For more information, visit Amgen.com and follow us on Twitter, LinkedIn, Instagram, TikTok and YouTube.
CONTACT: Amgen, Thousand Oaks
Megan Fox, 805-447-1423 (media)
Jessica Akopyan, 805-447-0974 (media)
Arvind Sood, 805-447-1060 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2022-credit-suisse-global-healthcare-conference-301668669.html
SOURCE Amgen
FAQ
What is the date and time of Amgen's presentation at the Credit Suisse Healthcare Conference?
Who will be presenting at the Credit Suisse Global Healthcare Conference?
Where can I watch the Amgen presentation from the Credit Suisse Conference?
How long will the Amgen webcast be available for replay?
What does Amgen focus on as a biotechnology company?
